These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver. García-Sáinz JA; Martínez-Alfaro M; Romero-Avila MT; González-Espinosa C J Endocrinol; 1997 Jul; 154(1):133-8. PubMed ID: 9246947 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814 [TBL] [Abstract][Full Text] [Related]
4. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo. Brown DC; Steward LJ; Ge J; Barnes NM Br J Pharmacol; 1996 May; 118(2):414-20. PubMed ID: 8735646 [TBL] [Abstract][Full Text] [Related]
5. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Lopez JJ; Lorell BH; Ingelfinger JR; Weinberg EO; Schunkert H; Diamant D; Tang SS Am J Physiol; 1994 Aug; 267(2 Pt 2):H844-52. PubMed ID: 8067441 [TBL] [Abstract][Full Text] [Related]
6. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro. Herbert JM; Delisée C; Dol F; Schaeffer P; Cazaubon C; Nisato D; Chatelain P Eur J Pharmacol; 1994 Jan; 251(2-3):143-50. PubMed ID: 8149971 [TBL] [Abstract][Full Text] [Related]
7. [125I]EXP985: a highly potent and specific nonpeptide radioligand antagonist for the AT1 angiotensin receptor. Chiu AT; McCall DE; Roscoe WA Biochem Biophys Res Commun; 1992 Nov; 188(3):1030-9. PubMed ID: 1445340 [TBL] [Abstract][Full Text] [Related]
8. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa. Boulay G; Servant G; Luong TT; Escher E; Guillemette G Mol Pharmacol; 1992 Apr; 41(4):809-15. PubMed ID: 1569928 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. Goldenberg I; Grossman E; Jacobson KA; Shneyvays V; Shainberg A J Hypertens; 2001 Sep; 19(9):1681-9. PubMed ID: 11564990 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Sumners C; Tang W; Zelezna B; Raizada MK Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7567-71. PubMed ID: 1881896 [TBL] [Abstract][Full Text] [Related]
11. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart. Scott AL; Chang RS; Lotti VJ; Siegl PK J Pharmacol Exp Ther; 1992 Jun; 261(3):931-5. PubMed ID: 1602398 [TBL] [Abstract][Full Text] [Related]
12. The angiotensin AT2 receptor is present in the human fetal adrenal gland throughout the second trimester of gestation. Breault L; Lehoux JG; Gallo-Payet N J Clin Endocrinol Metab; 1996 Nov; 81(11):3914-22. PubMed ID: 8923838 [TBL] [Abstract][Full Text] [Related]
13. [Angiotensin receptors in the rat myocardium during pre- and postnatal development]. Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E Cardiologia; 1993 Jul; 38(7):471-6. PubMed ID: 8221742 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats. Wong PC; Christ DD; Timmermans PB Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249 [TBL] [Abstract][Full Text] [Related]
17. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors]. Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407 [TBL] [Abstract][Full Text] [Related]
18. Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells. Smith RD FEBS Lett; 1995 Oct; 373(3):199-202. PubMed ID: 7589465 [TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats. Tofovic SP; Pong AS; Jackson EK Hypertension; 1991 Dec; 18(6):774-82. PubMed ID: 1743758 [TBL] [Abstract][Full Text] [Related]
20. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174. Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]